Pharma: Clinic Roundup
Teva Pharmaceutical Industries Ltd., of Jerusalem, said results of a Phase III trial of Milprosa (progesterone) vaginal ring were published in Fertility and Sterility.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.